Tibilin

Quick links to important sections

Tibilin

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Tibilin

What is Tibilin?

Tibilin is a pharmacological agent that belongs to the class of medications known as tetracycline antibiotics. It is primarily used in the management of various bacterial infections. As a broad-spectrum antibiotic, it works by interfering with the ability of bacteria to produce essential proteins necessary for their growth and reproduction.

Mechanism of Action

The active component in Tibilin exerts its effect by binding to the 30S ribosomal subunit of susceptible bacteria. By doing so, it prevents the attachment of aminoacyl-tRNA to the mRNA-ribosome complex, effectively inhibiting protein synthesis. This action is generally bacteriostatic, meaning it stops the bacteria from multiplying rather than killing them outright, allowing the body's immune system to eliminate the remaining microorganisms.

Clinical Applications

Tibilin is utilized in clinical settings to treat a range of conditions, including:

  • Respiratory tract infections: Such as pneumonia and chronic bronchitis.
  • Urinary tract infections: Caused by susceptible strains of bacteria.
  • Skin and soft tissue infections: Including certain types of acne and cellulitis.
  • Specific infections: It may also be used for infections caused by Rickettsiae, Chlamydia, and certain mycoplasma species.

General Characteristics

As a member of the tetracycline family, Tibilin is characterized by its four-ring structure. It is designed to be absorbed through the gastrointestinal tract and distributed throughout various body tissues and fluids. Its chemical stability and pharmacokinetic profile make it a versatile option for addressing systemic infections where the causative pathogen is known or suspected to be sensitive to this class of medication.

Regulatory References

  1. World Health Organization's List of Essential Medicines
  2. gold standard for oral iron supplementation

What side effects are possible with Tibilin?

Adverse Reaction Scope

Tibilin (tibolone) carries a safety profile defined by its complex hormonal activities. Officially documented serious adverse reactions include an increased risk of stroke, venous thromboembolism (such as Deep Venous Thrombosis and Pulmonary Embolism), and the potential for certain hormone-dependent malignancies. The risk of breast cancer recurrence is increased in women with a history of the disease, and for women with an intact uterus, there is an established risk of endometrial cancer.

Common and Less Frequent Effects

Commonly reported adverse effects often involve the reproductive system and general disorders. These may include vaginal bleeding or spotting (especially during initial months), headache, migraine, dizziness, nausea, abdominal pain, oedema, pruritus, and increase in body weight. Some women may also experience androgenic effects like abnormal hair growth or acne.

Safety Restrictions and Monitoring

Regulatory agencies impose strict contraindications, including known or suspected breast or endometrial cancer, a history of arterial or venous thromboembolic disease (e.g., stroke, heart attack, DVT/PE), severe liver disease, and undiagnosed abnormal genital bleeding. Treatment requires regular monitoring, including breast examinations and, for women with a uterus, assessment for abnormal bleeding or endometrial changes. Therapy must be immediately discontinued if serious conditions like jaundice, a significant increase in blood pressure, or new-onset migraine-type headaches occur.

This safety information underscores the necessity of a rigorous risk-benefit evaluation before and during the use of Tibilin, primarily focusing on managing cardiovascular and cancer risks.

Overdose and Emergency Response

Overdose and When to Seek Help

Tibilin (Ferrous Sulfate) overdose is a medical emergency that can lead to severe systemic toxicity. Official regulatory documents stress that accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under six.

Immediate emergency action is required in all cases of suspected overdose. The governing labels state to seek professional assistance immediately by calling a doctor or a Poison Control Center.

Documented Overdose Presentations

Classification Manifestations Listed in Regulatory Sources
Initial Toxicity Severe vomiting, diarrhoea, abdominal pain, hypotension (low blood pressure), and tachycardia (rapid heart rate).
Severe Outcomes Shock, metabolic acidosis, convulsions, coma, and potential late-stage hepatic necrosis (liver damage) and renal failure.

Emergency Management and Antidote

Management of iron overdose may involve hospital monitoring of serum iron levels, cardiac rhythm, and blood pressure. The specific iron chelating agent Deferoxamine mesylate is documented as the antidote for severe toxicity. Procedural measures described include gastric lavage or Whole Bowel Irrigation (WBI) to remove unabsorbed material. Overdose is particularly dangerous to young children, and any instance requires immediate medical attention.

Therapeutic Uses of Tibilin

What Tibilin treats: main uses and benefits

Tibilin may be part of symptomatic management applied across domains where additional symptomatic support is needed in situations where patients experience symptoms that interfere with daily functioning. The medication is considered relevant for managing conditions characterized by periods of heightened symptoms related to systemic imbalance.

In clinical settings that involve acute or unstable symptom patterns associated with postmenopausal changes, it may assist with managing risks associated with functional stability that becomes affected, such as bone density loss. Tibilin is commonly used to help with domains involving certain distressing symptoms and conditions where functional stability becomes affected.

Tibilin supports the patient during difficult episodes by easing distress and may assist with maintaining functional stability when symptoms are more noticeable. It is relevant in contexts involving heightened systemic burden.

“Tibilin supports general well-being during symptomatic phases and may help patients cope more steadily with symptom fluctuations.”

This provision of supportive relief may contribute to easing the overall symptom load and helps improve day-to-day comfort during symptomatic periods.

Quick Fact: Relevant for symptoms related to physical discomfort and systemic imbalance.

Eligibility and Restrictions for Use

Eligibility and Contraindications for Tibilin (Ferrous Sulfate)

Official regulatory documentation establishes specific populations who can or cannot use Tibilin. The medicine is primarily for Adults and Adolescents (12 years and over) for the treatment or prevention of iron deficiency. Use is considered acceptable for Pregnant and Breastfeeding women, though specific medical advice is required, particularly during the first trimester of pregnancy.

Absolute Contraindications

Use of Tibilin is absolutely contraindicated in patients with conditions involving iron overload, which includes Haemochromatosis or Haemosiderosis. The medicine must also not be used by patients receiving repeated blood transfusions or those with Haemolytic Anaemia unless a co-existing iron deficiency has been confirmed. Additionally, patients with Active Peptic Ulcer or certain active inflammatory gastrointestinal conditions like Ulcerative Colitis are excluded.

Population-Specific Restrictions

Age Group / Condition Official Regulatory Status
Children under 12 years Adult-strength presentation is not recommended; use requires specialized pediatric preparations.
History of GI Disease Caution is advised for patients with a history of peptic ulcers or inflammatory bowel disease.
Swallowing Difficulties Caution is required in older adults or those with difficulty swallowing due to risks of local tissue damage.
Other Anaemias Not recommended if the anaemia is due to deficiencies other than iron (e.g., Vitamin B12), unless iron deficiency is also present.

These official eligibility statements define who is permitted to use the medicine under standard conditions and who must be excluded to prevent risks related to iron overload or exacerbation of active disease.

What should I know about interactions with other medicines?

The official interaction profile for Tibilin (Ferrous Sulfate) is governed by pharmacokinetic interactions that primarily alter the gastrointestinal absorption of Tibilin or co-administered medicines. The iron cation can bind to certain substances, leading to a documented reduction in the systemic exposure of both agents. These absorption-based constraints necessitate specific administration timing requirements defined in regulatory labeling.

Interaction Patterns Requiring Separation

Co-administration with the following substances may significantly reduce the oral absorption of the co-administered agent. These interactions are managed by strict timing requirements:

Interacting Substance/Class Regulatory Outcome/Requirement
Quinolone Antibiotics (e.g., Ciprofloxacin) Reduced antibiotic absorption; requires administration to be separated by several hours.
Tetracycline Antibiotics Reduced absorption of both Tibilin and the antibiotic; requires specific spacing (e.g., 2 hours before or 3 hours after).
Levothyroxine (Thyroid Agent) Reduced Levothyroxine absorption; requires separation by at least 4 hours.
Bisphosphonates, Levodopa, Antacids Reduced absorption of these agents or Tibilin; requires administration separation (typically 1 to 4 hours).

Interactions with Food and Other Agents

The absorption of Tibilin itself is officially documented to be significantly affected by certain dietary products. Tea, coffee, eggs, and dairy products are documented to impair oral iron absorption and should be avoided near the time of administration. Conversely, co-administration with Ascorbic Acid is officially noted to increase iron absorption. Some strong chelating agents, such as Dimercaprol, are restricted due to the increased risk of nephrotoxicity.

Mechanism of Action

The drug Tibilin exerts its effect through a tissue-selective pharmacodynamic mechanism involving both receptor modulation and enzyme regulation cascades.

Selective Steroid Receptor Modulation

Tibilin functions as an agonist by engaging and activating the estradiol receptor in select tissues, such as bone. This selective receptor activation contributes to intracellular pathways that regulate specific cellular processes, including proliferation and apoptosis, resulting in tissue-specific modulation of genomic signaling.


Local Enzyme Activity Adjustment

The drug modulates local metabolic control by affecting specific enzyme activity within targeted tissues. This involves the selective inhibition of sulfatase and 17beta-hydroxysteroid dehydrogenase (HSD) type I, while simultaneously stimulating sulfotransferase and 17beta-HSD type II. This cascade alters early molecular steps, thereby modifying the local conversion of precursor hormones (like estrone sulfate) to active estrogens, leading to tissue-specific changes in local steroid levels.


Progestogenic and Androgenic Pathway Engagement

The primary Delta^4-metabolite of Tibilin engages mechanisms that influence feedback regulation within pathways. It acts as a progestagen in the uterus and displays androgenic activity in other systems, such as the brain and liver, modifying downstream signaling associated with these respective pathways.

Dosage and Administration Information

How to Use Tibilin (Ferrous Sulfate)

Tibilin is an oral iron preparation administered strictly by mouth to facilitate iron replacement. Its usage is governed by specific instructions related to dosage, timing, and preparation.


Official Administration Protocol

The standard adult regimen aims to provide 100 mg to 200 mg of elemental iron daily for treatment purposes. This elemental iron content is typically supplied by a ferrous sulfate salt in the form of tablets or liquid, which may be taken once daily or in divided doses. Prophylactic use generally requires lower doses, such as the equivalent of 60 mg of elemental iron once daily.

Administration Element Procedural Rule
Route & Form Integrity Tablets must be swallowed whole with water; they must not be crushed, chewed, or sucked, especially if they are extended-release or enteric-coated.
Timing with Food May be taken with or immediately after food for better tolerance, though maximum absorption often occurs when taken on an empty stomach (e.g., 30 minutes before a meal).
Pediatric Dosing Doses for children are typically weight-based, calculated in the range of 3 mg/kg/day to 6 mg/kg/day of elemental iron, administered in divided doses.

Duration and Special Conditions

Treatment duration is not defined by a fixed time but by the correction of the iron deficit and the full replenishment of the body's iron stores. This requires the medicine to be continued for an extended period, generally 3 to 6 months after blood markers have returned to normal levels. When taking liquid forms, these must be diluted and measured with a calibrated device to ensure dosage accuracy and prevent temporary staining of the teeth. Proper use also requires separating Tibilin intake from certain other medications by at least two hours to prevent interference with absorption.

Recent Clinical Evidence

Tibilin: Recent Clinical Evidence

Clinical research on Tibilin has primarily focused on its use in postmenopausal women to address common symptoms and manage bone health. The evidence gathered spans multiple phases of clinical trials, including large-scale randomized controlled trials (RCTs).


Study Design and Pharmacological Research

Early studies characterized the compound's pharmacokinetics and pharmacodynamics, examining how the compound moves through and affects the body. These evaluations, typically conducted under medical supervision, focused on absorption, metabolism, and excretion in healthy populations.

Outcomes in Menopausal Symptoms

Studies comparing Tibilin to other hormone replacement therapies (HRT) suggest that Tibilin is generally similar in effectiveness for relieving vasomotor symptoms (e.g., hot flashes). Key areas of differentiation noted in the research include:

Outcome Area Study Observation
Sexual Function Studies reported greater association with improvement in sexual interest and function compared to some conventional therapies.
Vaginal Bleeding Lower incidence of unscheduled vaginal bleeding and breast tenderness was observed with Tibilin compared to some continuous combined therapies.

Bone Health and Fracture Risk

Several studies have evaluated Tibilin's association with bone mineral density (BMD), a measure of bone strength. Treatment with Tibilin has been associated with increases in BMD in the lumbar spine and hip in postmenopausal women with and without osteoporosis.

  • Long-term Data: The Long-term Intervention on Fractures with Tibolone (LIFT) study, conducted in older women with osteoporosis, investigated fracture risk. This study indicated that Tibilin was associated with a reduced risk of vertebral fractures.

Important Safety and Risk Data

While Tibilin is generally observed to be well-tolerated, large-scale studies have shown that the compound was associated with an increased risk of stroke in older women with osteoporosis, particularly those in the higher age range. This risk was not consistently observed across all studies, particularly in younger postmenopausal populations.

Frequently Asked Questions (FAQ)

Common questions about Tibilin (FAQ)

Q: How quickly does Tibilin usually start working?

A: While the process of fully replenishing the body's iron stores can take several months of continued treatment, official health sources indicate that patients often start to feel an improvement in their symptoms related to iron deficiency within about three to four weeks of starting Tibilin. A healthcare provider determines the full duration required for iron deficiency correction.


Q: What are the most common things people feel when starting Tibilin?

A: Commonly reported temporary effects, especially when first starting Tibilin (Ferrous Sulfate), often involve the gastrointestinal system. These include nausea, vomiting, diarrhea, constipation, and general abdominal pain. Official information also notes that passing green or dark-colored stools is a common and expected occurrence while taking the medicine.


Q: Is it normal to feel tired when taking Tibilin?

A: Feeling fatigue or tiredness is generally not listed as a common side effect of Tibilin itself in official regulatory documents. However, profound tiredness is one of the key symptoms of the iron deficiency that Tibilin is prescribed to correct, and this symptom may be expected to gradually improve as the medicine corrects the iron deficiency.


Q: How is Tibilin different from [similar drug name]? (General difference)

A: Tibilin is an oral iron product whose active ingredient is Ferrous Sulfate, which is a specific chemical form of iron salt. This preparation is widely recognized as a standard form of oral iron replacement. Other products that treat iron deficiency may use different iron salts, such as ferrous fumarate or ferrous gluconate, which slightly alters the composition.


Q: Does Tibilin interact with common vitamins or supplements?

A: Yes, Tibilin's absorption can be affected by certain supplements. Official product information notes that iron absorption is improved when taken with Vitamin C (Ascorbic Acid). Conversely, iron can interfere with the absorption of other minerals like calcium and zinc, which may be present in many common multivitamins or supplements.


Q: What happens if I forget to take a dose of Tibilin?

A: Official patient information often advises that if a dose is missed, it should be taken as soon as it is remembered. However, if it is nearly time for the next scheduled dose, the missed dose should be skipped entirely. Official guidance states that a double dose should not be taken to make up for a single missed dose.


Q: Can Tibilin be taken with alcohol? (General information)

A: General guidance from health authorities states that the consumption of alcohol is typically allowed while taking Tibilin (Ferrous Sulfate). However, excessive alcohol use may potentially interfere with iron absorption and could also worsen common stomach-related side effects such as nausea or stomach upset.


Q: Does Tibilin have an effect on mood or behavior?

A: Mood or behavioral changes are not typically listed among the adverse reactions in the official regulatory labeling for Ferrous Sulfate. However, the condition Tibilin treats, iron deficiency anemia, can sometimes be associated with low mood or cognitive symptoms, and these may be expected to improve as the iron deficiency is corrected.


Q: What information is available about stopping Tibilin?

A: The decision to stop Tibilin is based on laboratory results. Treatment is continued until blood markers have returned to normal and the body’s iron reserves are fully replenished, which can take several months, often three to six months after the deficiency has been corrected. The decision to stop treatment is made by a healthcare provider following monitoring.


Q: Can Tibilin interact with birth control pills?

A: Official regulatory labeling for Ferrous Sulfate does not specifically list interactions with hormonal birth control pills. As the primary concern with iron is absorption, proper timing is important when taking any oral medication.


Q: Does Tibilin require special monitoring while taking it?

A: Yes, monitoring is required while on Tibilin. This typically involves blood tests to check iron levels (e.g., hemoglobin and serum ferritin) to confirm that the medicine is working effectively, to check for a sufficient response, and to confirm when the iron stores are fully restored.


Q: Are there any known delayed side effects of Tibilin?

A: Official drug documents focus primarily on common effects during treatment and risks from long-term, inappropriate use, and do not typically describe common delayed side effects occurring years after discontinuation.


Q: Can Tibilin cause sensitivity to the sun?

A: Increased sensitivity to the sun, or photosensitivity, is not listed as a side effect or warning in the official regulatory documents for Tibilin (Ferrous Sulfate).


Q: Why is Tibilin sometimes prescribed for different conditions?

A: Tibilin (Ferrous Sulfate) is officially indicated for the treatment and prevention of iron deficiency and the resulting iron deficiency anemia. It is prescribed for a variety of patients because iron deficiency can be caused by many different underlying medical issues, such as chronic blood loss, dietary deficiencies, or conditions affecting nutrient absorption.


Q: Is there a generic version of Tibilin available?

A: Yes. The active ingredient in Tibilin, Ferrous Sulfate, is a well-established and widely available generic compound. Many manufacturers produce unbranded generic versions that contain the exact same active ingredient, strength, and intended use as the brand name product. Generic versions are required to meet the same strict quality and effectiveness standards.


Q: Can Tibilin be used by people with kidney issues? (General question)

A: Official health guidance often addresses the use of iron preparations in certain cases of anemia that result from chronic kidney disease. However, iron balance can be complex with kidney issues, and official regulatory statements indicate that its use in this population is determined by a healthcare provider.


Q: Does Tibilin have a warning about interaction with grapefruit?

A: Official regulatory documents and product labels for Tibilin (Ferrous Sulfate) do not list grapefruit or grapefruit juice as having a specific interaction with this medication.


Q: Is Tibilin considered a controlled substance?

A: No. Tibilin (Ferrous Sulfate) is classified as an iron supplement and is not listed as a controlled substance by U.S. or international drug enforcement agencies.


Q: Does Tibilin affect lab test results?

A: Yes. Official documents state that taking iron can interfere with the results of certain stool tests, such as those checking for occult blood. It can also cause stools to appear dark or green, which may affect visual assessments performed during clinical testing.


Q: Does Tibilin contain any ingredients that cause allergies?

A: Regulatory labels list both the active ingredient, Ferrous Sulfate, and all inactive ingredients (excipients) used in the formulation. Patients with known allergies to any component listed in the official product information should avoid its use. Official patient information advises that medical help should be sought immediately if signs of a serious allergic reaction are noticed.


Q: Is Tibilin a long-term treatment or a short-term one?

A: Tibilin is used in both capacities. It is considered a long-term treatment when used to fully correct an existing iron deficiency over several months. It may also be used in a short-term, preventative role during periods where a patient has increased iron requirements.


Q: Are there any specific lifestyle changes recommended when taking Tibilin?

A: Official documents place strong emphasis on managing dietary timing around administration—specifically, avoiding certain foods and drinks like tea, coffee, and dairy near the time of dosing to maximize absorption. No other broad changes to general lifestyle are universally recommended in the official labeling.


Q: Is Tibilin known to cause weight changes?

A: Weight changes are not typically listed among the common adverse effects of Tibilin (Ferrous Sulfate) in official regulatory documents.


Q: Can Tibilin be used to treat [specific non-labeled condition]?

A: Official regulatory indications strictly define Tibilin's use for the prevention and treatment of iron deficiency and iron deficiency anemia. Official documents do not permit or discuss its use for any other medical conditions.


Q: Is Tibilin safe to take if I have high blood pressure? (General question)

A: High blood pressure (hypertension) itself is not listed as a contraindication or warning in the official regulatory documents for Tibilin (Ferrous Sulfate). However, like with all medical conditions, the decision to use Tibilin is determined by a healthcare provider.


Q: Are there any known interactions between Tibilin and herbal remedies?

A: Official patient guidance notes that a healthcare provider should be informed before combining herbal remedies or any other supplements with Tibilin. This is because some herbal products may contain minerals like iron, calcium, or zinc that could potentially affect the absorption of Tibilin or be absorbed less effectively themselves.


Q: What is the difference between the brand name and generic Tibilin?

A: The essential difference is the labeling and manufacturer. Generic Ferrous Sulfate is required by regulatory bodies to contain the exact same active ingredient (Ferrous Sulfate) in the same strength and form as the brand name product. Generic versions must meet the same strict quality and effectiveness standards as the brand-name drug.

How should Tibilin be stored and disposed of?

How to Store and Dispose of Tibolone (Tibilin)

Official regulatory documents detail specific conditions required to maintain the stability and effectiveness of the medicine. This information is non-advisory and solely reflects labeled instructions.

Storage Component Official Requirement
Temperature Does not require any special temperature storage conditions.
Protection Store in the original package. Protect from light and moisture.
Shelf-Life Do not use after the expiry date printed on the packaging.
Child Safety Keep this medicine out of the sight and reach of children.
Disposal Any unused or expired product must be disposed of in accordance with local requirements.

Disposal in line with local regulations helps protect the environment and avoids throwing the medicine away via household waste or wastewater.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Tibilin found in:

A-Z Index: